Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma
Clinical trial NCT03535350 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03535350
- Sponsor
- Case Comprehensive Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-24
- Primary completion
- 2023-04-04
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.